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Abstract: We investigated three related Rough Collies with recurrent inflammatory pulmonary 
disease. The clinical symptoms were similar to primary ciliary dyskinesia (PCD). However, the 
affected dogs did not carry any known pathogenic PCD variants. Pedigree analysis suggested a 
recessive mode of inheritance. Combined linkage and homozygosity mapping in three cases and 
seven non-affected family members delineated 19 critical intervals on 10 chromosomes comprising 
a total of 99 Mb. The genome of one affected dog was sequenced and compared to 601 control 
genomes. We detected only a single private homozygous protein-changing variant in the critical 
intervals. The detected variant was a 4 bp deletion, c.2717_2720delACAG, in the AKNA gene 
encoding the AT-hook transcription factor. It causes a frame-shift introducing a premature stop 
codon and truncates 37% of the open reading frame, p.(Asp906Alafs*173). We genotyped 88 Rough 
Collies consisting of family members and unrelated individuals. All three available cases were 
homozygous for the mutant allele and all 85 non-affected dogs were either homozygous wildtype 
(n = 67) or heterozygous (n = 18). AKNA modulates inflammatory immune responses. Akna−/− 
knockout mice die shortly after birth due to systemic autoimmune inflammatory processes 
including lung inflammation that is accompanied by enhanced leukocyte infiltration and alveolar 
destruction. The perfect genotype-phenotype association and the comparative functional data 
strongly suggest that the detected AKNA:c.2717_2720delACAG variant caused the observed severe 
airway inflammation in the investigated dogs. Our findings enable genetic testing, which can be 
used to avoid the unintentional breeding of affected puppies. 
Keywords: Canis lupus familiaris; dog; whole genome sequence; animal model; AT-hook 
transcription factor; immunology; inflammation; infection; rare disease; precision medicine 
 
1. Introduction 
Inherited forms of recurrent pneumonia or inflammatory airway disease are often due to 
primary ciliary dyskinesia (PCD) in humans and domestic animals. PCD is characterized by a loss of 
function of the motile cilia, not only in the lung, but also in the paranasal sinuses, the middle ear, 
sperm, the female reproductive tract and the ependyma of the brain. A defect in the structure or the 
function of the cilia typically leads to recurring infections of the upper and lower respiratory tract. 
The underlying pathogenesis is a decreased mucociliary clearance of dust and infectious agents [1]. 
Variants in over 40 genes are known to cause PCD in humans [2–4]. PCD causative genetic variants 
were also reported in purebred dogs. Variants in CCDC39 [5] and NME5 [6] were identified in PCD 
affected Old English Sheepdogs and Alaskan Malamutes, respectively. Despite the extensive 
knowledge about PCD, there are also clinically described forms of inherited recurrent inflammatory 
airway disease in humans and dogs, whose underlying genetic cause is still unknown [7,8]. Changes 
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to the cilia may also result from respiratory disease and are then termed secondary ciliary dyskinesia 
(SCD). Discrimination of PCD and SCD based on clinical signs and/or pathological findings can be 
challenging and is not routinely available in veterinary medicine [9]. 
Dog owners recently noticed several closely related Rough Collies with recurrent pulmonary 
disease, which clinically resembled canine forms of PCD. The goal of this study was to identify the 
underlying causative genetic defect. 
2. Materials and Methods 
2.1. Ethics Statement 
All animal experiments were performed according to local regulations. All dogs in this study 
were privately owned and examined with the consent of their owners. The “Cantonal Committee for 
Animal Experiments” approved the collection of blood samples (Canton of Bern; permit 75/16). 
2.2. Animal Selection 
This study included 88 Rough Collies. Three related Rough Collies, two of them being half 
siblings, had recurrent pulmonary disease as reported by the owners. The other 85 dogs were 
reported as unaffected by their owners. EDTA blood samples were collected for DNA isolation. We 
also used 539 dogs of various other breeds, which had been donated to the Vetsuisse Biobank (Table 
S1). They represented population controls without reports of recurrent pulmonary diseases. 
2.3. DNA Extraction and Genotyping 
Genomic DNA was isolated from EDTA blood with the Maxwell RSC Whole Blood Kit using a 
Maxwell RSC instrument (Promega, Dübendorf, Switzerland). Ten Rough Collies consisting of 3 
cases and 7 control dogs from an extended family were genotyped on the Illumina canine_HD 
BeadChips containing 220,853 markers (Neogen, Lincoln, NE, USA). 
2.4. Linkage and Homozygosity Mapping 
The genotype data of 3 non-affected parents, 2 affected and 4 non-affected offspring in two litters 
were used for a parametric linkage analysis. Using PLINK v 1.09 [10], markers that were non-
informative, located on the sex chromosomes, or missing in any of the nine dogs, containing Mendel 
errors, or having a minor allele frequency <0.05 were excluded. The final dataset contained 65,446 
markers. Parametric linkage analysis using an autosomal recessive inheritance model with full 
penetrance and a disease allele frequency of 0.4 was performed with the Merlin software [11]. 
For homozygosity mapping, the genotype data of the three affected dogs were used. The --
homozyg and --homozyg -group options in PLINK were used to search for extended regions of 
homozygosity >1 Mb. The output intervals were matched against the intervals from linkage analysis 
in Excel spreadsheets to find overlapping regions. The raw single nucleotide variant (SNV) genotypes 
are available in S1. The output of the linkage and homozygosity mapping is given in Table S2. 
2.5. Whole Genome Sequencing of an Affected Rough Collie 
An Illumina TruSeq PCR-free DNA library with 500 bp insert size of an affected Rough Collie 
(CL013) was prepared. We collected 227 million 2 × 150 bp paired-end reads on a NovaSeq 6000 
instrument (26.9× coverage). Mapping and alignment were performed as described [12]. The 
sequence data were deposited under study accession PRJEB16012 and sample accession 
SAMEA4867926 at the European Nucleotide Archive. 
2.6. Variant Calling 
Variant calling was performed using GATK HaplotypeCaller [13] in gVCF mode as described 
[9]. To predict the functional effects of the called variants, SnpEff [14] software together with NCBI 
annotation release 105 for the CanFam 3.1 genome reference assembly was used. For variant filtering 
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we used 601 control genomes, which were either publicly available [15] or produced during other 
projects of our group [16] (Table S3). 
2.7. Gene Analysis 
We used the dog CanFam 3.1 reference genome assembly for all analyses. Numbering within 
the canine AKNA gene corresponds to the NCBI RefSeq accessions XM_014117950.2 (mRNA) and 
XP_013973425.1 (protein). 
2.8. Sanger Sequencing 
The AKNA:c.2717_2720delACAG variant was genotyped by direct Sanger sequencing of PCR 
amplicons. A 305 bp (or 301 bp for the deletion allele) PCR product was amplified from genomic 
DNA using AmpliTaqGold360Mastermix (Thermo Fisher Scientific, Waltham, MA, USA) together 
with primers 5′-CCT GTG AGC CTC TGG AAT GT-3′ (Primer F) and 5′-CTG AGA ATG CCC AGA 
CCA TC-3′ (Primer R). After treatment with exonuclease I and alkaline phosphatase, amplicons were 
sequenced on an ABI 3730 DNA Analyzer (Thermo Fisher Scientific). Sanger sequences were 
analyzed using the Sequencher 5.1 software (GeneCodes, Ann Arbor, MI, USA). 
3. Results 
3.1. Phenotype Description 
The owners reported recurrent foamy vomiting, shallow breathing, coughing, increased 
breathing sounds, nasal discharge and fever in three related Rough Collies. Bronchopneumonia was 
diagnosed by a private veterinarian. The clinical signs started at a few days of age in two affected 
dogs. The dogs responded to therapy with antibiotics and secretolytics. However, they tended to 
relapse quickly. Two dogs were reported to be alive at three years with frequent yellowish nasal 
discharge. No information on the course of the disease is available for the third affected dog. 
3.2. Genetic Analysis 
Three related cases were reported. The pedigree of these dogs is shown in Figure 1 and 
suggested autosomal recessive inheritance. Linkage analysis using two litters with six offspring (two 
affected, four non-affected) and their three parents showed 18 linked genome segments totaling 246 
Mb. We additionally performed homozygosity mapping in the three affected dogs. They shared 87 
homozygous segments with identical alleles totaling 354 Mb. Intersecting the linked and 
homozygous regions delineated critical intervals comprising 19 segments on 10 chromosomes 
spanning 99 Mb or roughly 4.1% of the 2.4 Gb dog genome. The two known canine PCD causative 
variants, CCDC39:c.286C>T [5] and NME5:c.43delA [6] were not located in the critical intervals and 
could thus be excluded. 
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Figure 1. Pedigree of the three investigated cases. Filled symbols represent dogs with recurrent 
inflammatory pulmonary disease. Open symbols represent non-affected dogs. 
AKNA:c.2717_2720delACAG genotypes are indicated for all dogs, from which a DNA sample was 
available. The laboratory identifiers of the 10 dogs that were genotyped on the SNV microarray for 
linkage and homozygosity mapping are underlined. The grey rectangle indicates the 9 dogs that were 
used for linkage analysis.  
We sequenced the genome of an affected dog at 26.9× coverage and called SNVs and short indels 
with respect to the CanFam3.1 genome assembly. We then searched for private homozygous variants 
in the genome sequence of the affected dog that were not present in 601 control dogs of different 
breeds (Table 1). We identified only one private homozygous protein-changing variant in the critical 
intervals (Table S4). 
Table 1. Results of variant filtering in an affected dog and 601 control genomes. 
Filtering Step Homozygous Variants 
variants in the whole genome 3,378,300 
private variants in the whole genome 1332 
protein-changing private variants in the whole genome 7 
protein-changing private variants in critical intervals 1 
This variant represented a 4 bp deletion that can be designated as 
Chr11:68,576,241_68,576,244delCTGT (CanFam 3.1 assembly). It was located in the AKNA gene 
encoding AT-hook transcription factor and is predicted to result in a frameshift of the coding 
sequence, XM_014117950.2:c.2717_2720delACAG. The variant introduces a premature stop codon. 
Due to a lack of suitable RNA samples we did not experimentally investigate whether the mutant 
transcripts are subject to nonsense-mediated decay and/or nonsense-mediated alternative splicing. If 
expressed, the predicted translation product of the mutant transcript would lack 529 amino acids of 
the 1434 amino acid wildtype AKNA protein and contain 172 new amino acids at its C-terminus. The 
formal variant designation is XP_013973425.1:p.(Asp906Alafs*173). We confirmed the presence of the 
AKNA:c.2717_2720delACAG variant in genomic DNA samples by Sanger sequencing (Figure 2). 
 
Figure 2. Details of the AKNA:c.2717_2720delACAG variant. Representative electropherograms of a 
control and an affected dog are shown. The four deleted bases are indicated by the square. Altered 
amino acid translations are shown in red. 
We genotyped a total of 627 dogs for the variant and observed perfect genotype-phenotype 
concordance (Table 2). All three affected Rough Collies carried the deletion in the homozygous state. 
Eighteen non-affected dogs were heterozygous and presumed carriers. The remaining 67 non-
affected Rough Collies were homozygous wildtype. As we tested only a relatively small number of 
Rough Collies including many close relatives of the affected dogs, we cannot reliably estimate the 
allele frequency in the breed. The mutant allele at the AKNA:c.2717_2720delACAG variant was absent 
from 539 additionally genotyped dogs of various breeds (Table S1). 
Table 2. Genotype-phenotype association of the AKNA:c.2717_2720delACAG variant. 
Dogs wt/wt wt/del del/del 
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Cases, Rough Collies (n = 3) 0 0 3 
Controls, Rough Collies (n = 85) 67 18 0 
Controls, various dog breeds (n = 539) 539 0 0 
4. Discussion 
In this study, we identified AKNA:c.2717_2720delACAG as a candidate causative variant for an 
inherited form of recurrent inflammatory pulmonary disease in dogs. The affected dogs were initially 
submitted with a suspected diagnosis of PCD. We therefore were surprised that the candidate 
causative variant turned out to be unrelated to cilial function. The clinical phenotype has not yet been 
characterized in detail. We putatively propose the term recurrent inflammatory pulmonary disease 
to emphasize the phenotypic similarities of the affected dogs with Akna−/− knockout mice (see below). 
AKNA encodes the AT-hook transcription factor, which has an important regulatory function in 
the immune system. It modulates the transcription of CD40 and its ligand CD154 (also called CD40L) 
in immune cells [17]. The interaction of CD40 and CD154 has been shown to be involved in the 
negative regulation of T cell autoreactivity and abnormalities in their interaction may lead to 
autoimmunity. In human systemic autoimmune diseases such as Vogt-Koyanagi-Harada syndrome, 
AKNA was found to be downregulated in CD4+ T-lymphocytes [18]. Furthermore, associations 
between AKNA gene variants with knee osteoarthritis [19] and an elevated risk for cervical cancer 
due to a deregulation in the inflammasome network were reported [20,21]. To the best of our 
knowledge, no human patients affected by recurrent inflammatory pulmonary disease or any other 
pathology with germline coding variants in AKNA have been described in the scientific literature. 
Data from more than 120,000 humans in the gnomAD browser [22] indicate that AKNA loss of 
function (LoF) variants are less frequent than expected (19 observed vs 61.4 theoretically expected 
LoF variants). No individuals carrying an AKNA LoF variant in homozygous state have been 
identified so far. 
Akna−/− knockout mice are smaller than their wildtype littermates and they die within 10 days 
after birth due to systemic inflammation, predominantly seen in the lungs [23]. Enhanced leukocyte 
infiltration and a massive overproduction of pro-inflammatory cytokines and matrix 
metallproteinases lead to alveolar destruction in the Akna−/− knockout mice. The murine Akna gene 
contains 22 exons and two different knockout strains were investigated. The initial strain was 
constructed by deleting exons 19–21. It was not assessed whether a C-terminally truncated protein 
might be expressed in this particular strain [23]. This knockout strain closely resembles the situation 
in homozygous mutant Rough Collies, which have a shift of the reading frame starting in exon 13. 
Later, a second mouse knockout strain with a deletion of exon 3 was constructed. Exon 3 is the largest 
coding exon and encodes the first AT-hook motif of AKNA. Both Akna−/− mouse knockout strains 
exhibited comparable phenotypes [23]. 
The genetic investigations in dogs showed a perfect genotype-phenotype correlation of the 
AKNA variant with recurrent inflammatory pulmonary disease. This association supports a causative 
role of AKNA:c.2717_2720delACAG, however cannot provide definitive proof. Nonetheless, the 
known role of AKNA as an important anti-inflammatory regulator of the immune response and the 
striking phenotypic similarities of the affected dogs with Akna−/− knockout mice in combination with 
the genetic association strongly suggests that AKNA:c.2717_2720delACAG is the causative variant. 
5. Conclusions 
We identified AKNA:c.2717_2720delACAG as a candidate causative variant for an inherited, 
autosomal recessive, recurrent inflammatory pulmonary disease in Rough Collies. The findings from 
knockout mice and these dogs suggest that AKNA should be considered as a candidate gene for 
human patients with unexplained recurrent inflammatory pulmonary disease. Our findings enabled 
genetic testing for Rough Collies, which can be used to avoid the unintentional breeding of affected 
puppies. 
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Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, S1: Illumina 
canine_HD SNV genotypes of 10 Rough Collies, Table S1: AKNA:c.2717_2720delACAG genotypes of 539 control 
dogs. Table S2: Linkage and homozygosity mapping, Table S3: Accession numbers of 594 dog and 8 wolf genome 
sequences, Table S4: Private protein changing variants in the sequenced Rough Collie with recurrent 
inflammatory pulmonary disease. 
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